CASIA OpenIR  > 中国科学院分子影像重点实验室
Nuclear and Fluorescent Labeled PD-1-Liposome-DOX-Cu-64/IRDye800CW Allows Improved Breast Tumor Targeted Imaging and Therapy
Du, Yang1; Liang, Xiaolong2; Li, Yuan1,3; Sun, Ting1,3; Jin, Zhengyu3; Xue, Huadan3; Tian, Jie1
Source PublicationMOLECULAR PHARMACEUTICS
2017-11-01
Volume14Issue:11Pages:3978-3986
SubtypeArticle
AbstractThe overexpression of programmed cell death-1 (PD 1) in tumors as breast cancer makes it a possible target for cancer imaging and therapy. Advances in molecular imaging, including radionuclide imaging and near-infrared fluorescence (NIRF) imaging, enable the detection of tumors with high sensitivity. In this study, we aim to develop a novel PD-1 antibody targeted positron emission tomography (PET) and NIRF labeled liposome loaded with doxorubicin (DOX) and evaluate its application for in vivo cancer imaging and therapy. IRDye800CW and Cu-60 were conjugated to liposomes with PD-1 antibody labeling, and DOX was inside the liposomes to form theranostic nanopartides. The 4T1 tumors were successfully visualized with PD-1-LiposomeDOX-Cu-64/IRDye800CW using NIRF/PET imaging. The bioluminescent imaging (BLI) results showed that tumor growth was significantly inhibited in the PD-1-Liposome-DOX-treated group than the IgG control. Our results highlight the potential of using dual-labeled theranostic PD-1 mAb-targeted Liposome-DOX-Cu-64/IRDye800CW for the management of breast tumor.
KeywordProgrammed Cell Death-i (Pd-i) Near-infrared Fluorescence (Nirf) Imaging Pet Imaging Doxorubicin (Dox) Breast Cancer Therapy
WOS HeadingsScience & Technology ; Life Sciences & Biomedicine
DOI10.1021/acs.molpharmaceut.7b00649
WOS KeywordCELL LUNG-CANCER ; INFILTRATING LYMPHOCYTES ; ANTI-PD-L1 ANTIBODY ; DELIVERY-SYSTEMS ; POOR-PROGNOSIS ; CHEMOTHERAPY ; COMBINATION ; NIVOLUMAB ; EXPRESSION ; RESISTANCE
Indexed BySCI
Language英语
Funding OrganizationNational Natural Science Foundation of China(81227901 ; Research and Development Program of China (973)(2014CB748600 ; Strategic Priority Research Program from Chinese Academy of Sciences(XDB02060010) ; Beijing Natural Science Foundation(Z16110200010000) ; Peking University Third Hospital(BYSY2015023) ; 81470083 ; 2015CB755500) ; 81527805 ; 81571810 ; 61231004 ; 81771846)
WOS Research AreaResearch & Experimental Medicine ; Pharmacology & Pharmacy
WOS SubjectMedicine, Research & Experimental ; Pharmacology & Pharmacy
WOS IDWOS:000414820000034
Citation statistics
Cited Times:27[WOS]   [WOS Record]     [Related Records in WOS]
Document Type期刊论文
Identifierhttp://ir.ia.ac.cn/handle/173211/19589
Collection中国科学院分子影像重点实验室
Affiliation1.Chinese Acad Sci, Key Lab Mol Imaging, State Key Lab Management & Control Complex Syst, Inst Automat, Beijing 100190, Peoples R China
2.Peking Univ, Hosp 3, Dept Ultrasound, Beijing 100191, Peoples R China
3.Beijing Union Med Coll Hosp, Dept Radiol, Beijing 100006, Peoples R China
Recommended Citation
GB/T 7714
Du, Yang,Liang, Xiaolong,Li, Yuan,et al. Nuclear and Fluorescent Labeled PD-1-Liposome-DOX-Cu-64/IRDye800CW Allows Improved Breast Tumor Targeted Imaging and Therapy[J]. MOLECULAR PHARMACEUTICS,2017,14(11):3978-3986.
APA Du, Yang.,Liang, Xiaolong.,Li, Yuan.,Sun, Ting.,Jin, Zhengyu.,...&Tian, Jie.(2017).Nuclear and Fluorescent Labeled PD-1-Liposome-DOX-Cu-64/IRDye800CW Allows Improved Breast Tumor Targeted Imaging and Therapy.MOLECULAR PHARMACEUTICS,14(11),3978-3986.
MLA Du, Yang,et al."Nuclear and Fluorescent Labeled PD-1-Liposome-DOX-Cu-64/IRDye800CW Allows Improved Breast Tumor Targeted Imaging and Therapy".MOLECULAR PHARMACEUTICS 14.11(2017):3978-3986.
Files in This Item: Download All
File Name/Size DocType Version Access License
Acs.molpharmaceut-du(4708KB)期刊论文作者接受稿开放获取CC BY-NC-SAView Download
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Du, Yang]'s Articles
[Liang, Xiaolong]'s Articles
[Li, Yuan]'s Articles
Baidu academic
Similar articles in Baidu academic
[Du, Yang]'s Articles
[Liang, Xiaolong]'s Articles
[Li, Yuan]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Du, Yang]'s Articles
[Liang, Xiaolong]'s Articles
[Li, Yuan]'s Articles
Terms of Use
No data!
Social Bookmark/Share
File name: Acs.molpharmaceut-du.pdf
Format: Adobe PDF
This file does not support browsing at this time
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.